<DOC>
	<DOCNO>NCT01287520</DOCNO>
	<brief_summary>The purpose study determine recommend Phase 2 dose dose regimen LY2090314 combination pemetrexed carboplatin patient advanced/metastatic cancer . Part A study consist dose escalation study regimen , Part B consist expand cohort confirm dose provide Part A .</brief_summary>
	<brief_title>A Study LY2090314 Patients With Advanced Metastatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Have performance status less equal 2 Eastern Cooperative Oncology Group ( ECOG ) scale Have life expectancy great equal 12 week Males female reproductive potential agree use medically approve contraceptive precaution trial three month follow last dose study drug Have histological cytological evidence diagnosis cancer advance and/or metastatic disease proven effective therapy exists . Have presence measurable nonmeasurable disease define Response Evaluation Criteria Solid Tumors . Have adequate hematologic , hepatic , renal function . Have discontinue previous therapy cancer , include chemotherapy , radiotherapy , cancerrelated hormonal therapy , investigational therapy least 30 day ( 6 week mitomycinC nitrosoureas ) prior study enrollment recover acute effect therapy . Have receive treatment within 30 day initial dose study drug drug receive regulatory approval indication . Have serious preexist medical condition ( leave discretion investigator ) . Have one follow conduction abnormality : QTc prolongation &gt; 450 msec screen electrocardiogram ( ECG ) , previous history QTc prolongation another medication require discontinuation , congenital longQTsyndrome , leave bundle branch block ( LBBB ) . Are take concomitant medication may cause QTc prolongation , induce Torsades de Pointes . Have systolic blood pressure great than/equal 140 mm Hg , diastolic blood pressure great than/equal 90 mm Hg control medical therapy . Have serious cardiac condition , myocardial infarction within 6 month , angina , heart disease , define New York Heart Association Class II high . Patients history arrhythmia symptomatic require treatment . Have chronic atrial fibrillation and/or bradycardia . Have uncorrected electrolyte disorder include potassium &lt; 3.4 mEq/L ( &lt; 3.4 mmol/l ) , calcium &lt; 8.4 mg/dL ( 2.1 mmol/L ) , magnesium &lt; 1.2 mg/dL ( &lt; 0.62 mmol/L ) . Have symptomatic central nervous system malignancy metastasis ( screen require ) . Have hematologic malignancy . Females pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>